United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $682,841,294.43
- April 16, 2024
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 17, 2021 | Director | 2,103 | $170.00 | Sell | $357,510.00 | |
July 8, 2020 | CEO | 10,000 | $117.91 | Sell | $1,179,100.00 | |
July 6, 2020 | CEO | 10,000 | $119.60 | Sell | $1,196,000.00 | |
July 2, 2020 | CEO | 10,000 | $120.73 | Sell | $1,207,300.00 | |
June 30, 2020 | CEO | 10,000 | $120.36 | Sell | $1,203,600.00 | |
June 29, 2020 | Director | 4,600 | $116.81 | Sell | $537,326.00 | |
June 26, 2020 | CEO | 10,000 | $121.00 | Sell | $1,210,000.00 | |
June 24, 2020 | CEO | 30,000 | $119.54 | Sell | $3,586,200.00 | |
June 22, 2020 | CEO | 10,000 | $117.81 | Sell | $1,178,100.00 | |
June 19, 2020 | CEO | 20,000 | $116.35 | Sell | $2,327,000.00 | |
June 17, 2020 | CEO | 10,000 | $117.82 | Sell | $1,178,200.00 | |
June 15, 2020 | CEO | 10,000 | $113.87 | Sell | $1,138,700.00 | |
June 12, 2020 | CEO | 20,000 | $115.42 | Sell | $2,308,400.00 | |
June 10, 2020 | CEO | 30,000 | $122.86 | Sell | $3,685,800.00 | |
June 8, 2020 | Director | 4,510 | $124.96 | Sell | $563,569.60 | |
June 5, 2020 | CEO | 10,000 | $123.59 | Sell | $1,235,900.00 | |
June 3, 2020 | CEO | 10,000 | $124.52 | Sell | $1,245,200.00 | |
June 1, 2020 | CEO | 10,000 | $119.28 | Sell | $1,192,800.00 | |
May 29, 2020 | CEO | 10,000 | $115.91 | Sell | $1,159,100.00 | |
May 27, 2020 | CEO | 10,000 | $115.90 | Sell | $1,159,000.00 | |
May 5, 2020 | Director | 3,100 | $112.56 | Sell | $348,936.00 | |
April 20, 2020 | Director | 5,000 | $107.00 | Sell | $535,000.00 | |
April 14, 2020 | Director | 5,000 | $99.00 | Sell | $495,000.00 | |
March 26, 2020 | Director | 5,000 | $91.75 | Sell | $458,750.00 | |
June 27, 2019 | Director | 3,750 | $76.11 | Sell | $285,412.50 | |
June 20, 2019 | Director | 5,000 | $79.05 | Sell | $395,250.00 | |
March 7, 2019 | Director | 3,370 | $110.75 | Sell | $373,227.50 | |
Feb. 5, 2019 | Director | 400 | $117.00 | Sell | $46,800.00 | |
Jan. 30, 2019 | CEO | 14,108 | $115.77 | Sell | $1,633,283.16 | |
Jan. 28, 2019 | CEO | 14,108 | $115.37 | Sell | $1,627,639.96 | |
Jan. 24, 2019 | CEO | 7,054 | $113.95 | Sell | $803,803.30 | |
Jan. 22, 2019 | CEO | 7,054 | $113.35 | Sell | $799,570.90 | |
Jan. 17, 2019 | CEO | 14,108 | $113.70 | Sell | $1,604,079.60 | |
Jan. 15, 2019 | CEO | 14,108 | $114.85 | Sell | $1,620,303.80 | |
Jan. 10, 2019 | CEO | 14,108 | $113.51 | Sell | $1,601,399.08 | |
Jan. 8, 2019 | CEO | 7,054 | $113.16 | Sell | $798,230.64 | |
Jan. 4, 2019 | CEO | 7,055 | $111.51 | Sell | $786,703.05 | |
Sept. 10, 2018 | Director | 810 | $119.00 | Sell | $96,390.00 | |
Sept. 6, 2018 | Director | 810 | $118.00 | Sell | $95,580.00 | |
Aug. 16, 2018 | Director | 3,240 | $129.38 | Sell | $419,191.20 | |
Aug. 3, 2018 | Director | 580 | $127.48 | Sell | $73,938.40 | |
June 29, 2018 | Director | 3,240 | $113.07 | Sell | $366,346.80 | |
June 12, 2018 | Director | 600 | $112.38 | Sell | $67,428.00 | |
April 9, 2018 | CEO | 21,513 | $110.88 | Sell | $2,385,361.44 | |
April 5, 2018 | CEO | 21,512 | $114.30 | Sell | $2,458,821.60 | |
April 3, 2018 | CEO | 22,059 | $114.44 | Sell | $2,524,431.96 | |
March 29, 2018 | CEO | 43,024 | $111.14 | Sell | $4,781,687.36 | |
March 22, 2018 | CEO | 1,100 | $110.01 | Sell | $121,011.00 | |
March 20, 2018 | CEO | 301 | $110.48 | Sell | $33,254.48 | |
March 16, 2018 | CEO | 43,025 | $111.11 | Sell | $4,780,507.75 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, Louis W Sullivan, Tommy G Thompson, Nilda Mesa, Judy D Olian, Paul A. Mahon, Ray Kurzweil, Tommy G. Thompson, MAHON PAUL A, Judy D. Olian, DWEK RAYMOND, R Paul Gray, and Louis Sullivan
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 348 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $334,310,614.82.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on April 16, 2024.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Roger Jeffs with a total value of $6,551,000.00 on Sept. 23, 2014.